EVALUATING CPLA2 ACTIVITY IN APOE4 CSF AFTER PREVENTE4 DHA SUPPLEMENTATION

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline, neuroinflammation, amyloid plaques, and neurofibrillary tangles. The apolipoprotein E ε4 (APOE4) allele is the greatest genetic risk factor for late-onset AD.